Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: A randomised trial Academic Article uri icon

Overview

MeSH Major

  • Antitubercular Agents
  • HIV Infections
  • HIV-1
  • Isoniazid
  • Tuberculosis

abstract

  • The rate of recurrent tuberculosis is higher in HIV-1-positive individuals than in HIV-1-negative individuals, and is strongly associated with a history of symptomatic HIV-1 disease before initial tuberculosis diagnosis. Post-treatment isoniazid prophylaxis decreases the risk of recurrence in HIV-1-positive individuals, and should be considered for HIV-1-positive individuals with a history of HIV-1-related symptoms at the time of tuberculosis diagnosis.

publication date

  • October 28, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11081529

Additional Document Info

start page

  • 1470

end page

  • 4

volume

  • 356

number

  • 9240